SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event) April 19, 2012; (April 16, 2012)
GUIDED THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Its Charter)
| | | |
|---|
| Delaware | 0-22179 | 58-2029543 |
| (State or Other Jurisdiction of | (Commission File Number) | (IRS Employer Identification No.) |
| Incorporation) | | |
| | |
5835 Peachtree Corners East, Suite D Norcross, Georgia (Address of Principal Executive Offices) | 30092 (Zip Code) |
Registrant's Telephone Number, Including Area Code: (770) 242-8723
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | | |
| | o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | | |
| | o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | | |
| | o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| | | |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.
On April 16, 2012, the board of directors of Guided Therapeutics, Inc. appointed Linda Rosenstock, MD, MPH, as a director of the Company, effective immediately. In connection with her appointment, the board awarded Dr. Rosenstock with options to purchase 75,000 shares of the Company's common stock under its 1995 stock plan. The options have an exercise price of $0.81 per share. One-quarter of the options are immediately exercisable, and the remainder will vest in equal monthly installments through year end 2012. Dr. Rosenstock has not been named to a board committee at this time.
Dr. Linda Rosenstock, 61, is Dean of the University of California, Los Angeles (UCLA) Fielding School of Public Health. She holds appointments as Professor of Medicine and Environmental Health Sciences and is a recognized authority in broad areas of public health and science policy. Before coming to UCLA in 2000, Dr. Rosenstock served as Director of the National Institute for Occupational Safety and Health (NIOSH) for nearly seven years. She is also a director of Skilled Healthcare Group, Inc.
On April 17, the Company issued a news release announcing Dr. Rosenstock’s appointment, a copy of which is furnished as Exhibit 99.1 hereto and which is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits.
| | |
|---|
| Number | Exhibit |
| 99.1 | Press Release dated April 17, 2012 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | GUIDED THERAPEUTICS, INC. | |
| | | | |
| | By: | /s/ Mark L. Faupel, Ph.D. | |
| | | Mark L. Faupel, Ph.D. | |
| | | CEO & President | |
| Date: April 19, 2012 | | | |
